Wellous, a Malaysia-based nutrition company, has entered a merger agreement with special purpose acquisition firm Kairous Acquisition Corp Ltd. Following the completion of this deal, Wellous will be publicly listed on Nasdaq.
Team Wellous / Photo credit: Wellous
The merger consideration is worth US$270 million – an amount that will be payable through the freshly issued securities of the merged entity, which will be valued at US$10.10 per share. Through the deal, there will also be cash proceeds, which will be made up of Kairous’s approximately US$21 million in trust.
Founded in 2016 by Andy Tan and Henry Chin, the company develops, creates, markets, and sells health food and wellness supplements through its tech-enabled platform.
It lists 10 brands on its website, offering a variety of products – from its Immority anti-aging formulation to its Zenso weight management supplements.
The global dietary supplement market is set to grow to US$240.9 billion by 2028 at a compound annual growth rate of 8.5%.
See also: Exclusive: GFC leads $3m+ seed round in Indonesian health and wellness startup
Editing by Samreen Ahmad and Jaclyn Tiu
(And yes, we’re serious about ethics and transparency. More information here.)
Stay updated on the go with our mobile app.
Get latest insights with smoother, more personalized experience through TIA mobile app.
📅 Upcoming Events
22 October 2026
Payoneer x CSPN Summit 2026